Juan Pablo Frias - 31 May 2024 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role
Chief Medical Officer
Signature
/s/ Franco Valle as Attorney-in-Fact for Juan Pablo Frias
Issuer symbol
BMEA
Transactions as of
31 May 2024
Net transactions value
+$3,121
Form type
4
Filing time
12 Jun 2024, 16:30:06 UTC
Previous filing
18 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Award $3,121 +349 $8.94 349 31 May 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on May 31, 2024.